Cargando…
Mesenchymal stem cells overexpressing IL-35: a novel immunosuppressive strategy and therapeutic target for inducing transplant tolerance
Inducing donor-specific immunological tolerance, which avoids the complications of long-term immunosuppression, is an important goal in organ transplantation. Interleukin-35 (IL-35), a cytokine identified in 2007, is mainly secreted by regulatory T cells (Tregs) and is essential for Tregs to exert t...
Autores principales: | Guo, Hao, Li, Baozhu, Wang, Wei, Zhao, Na, Gao, Haopeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158805/ https://www.ncbi.nlm.nih.gov/pubmed/30257721 http://dx.doi.org/10.1186/s13287-018-0988-9 |
Ejemplares similares
-
Strategies to improve the immunosuppressive properties of human mesenchymal stem cells
por: Lee, Myoung Woo, et al.
Publicado: (2015) -
Immunosuppressant Drugs Mitigate Immune Responses Generated by Human Mesenchymal Stem Cells Transplanted into the Mouse Parenchyma
por: Hwang, Jung Won, et al.
Publicado: (2021) -
Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges
por: Ebrahimi, Ammar, et al.
Publicado: (2014) -
PDGF-BB and IL-4 co-overexpression is a potential strategy to enhance mesenchymal stem cell-based bone regeneration
por: Zhang, Ning, et al.
Publicado: (2021) -
Immunosuppressive strategies in lung transplantation
por: Chung, Paul A., et al.
Publicado: (2020)